AMERICAN VANGUARD CORP 8-K

What Happened
American Vanguard Corporation (the Company) announced that on March 13, 2026 its subsidiary AMVAC Chemical Corporation (AMVAC) entered into two secured term loan facilities — a $225 million first‑lien term loan and a $60 million second‑lien term loan — and an intercreditor agreement governing lien priorities. The proceeds were used to refinance and retire the Company’s prior credit agreement (dated August 5, 2021) and other indebtedness, pay related fees and expenses, and for general corporate and working capital purposes. Wilmington Trust, N.A. and Centerbridge led the first‑lien lenders; BMO Bank N.A. led the second‑lien group.

Key Details

• Total new term loans: $285 million (First Lien $225M; Second Lien $60M), each with a five‑year term.
• Interest and fees: First‑lien margin initially 8.25% over SOFR (7.25% for base rate loans) with step‑downs based on leverage; a 1.00% per annum PIK (payable in kind) leverage fee applies while consolidated leverage >5.0:1. Second‑lien margin 2.00% over benchmark, subject to a 3.00% SOFR floor.
• Governance covenants: Company agreed to appoint one independent director to the Company’s Board within 90 days and to reduce Board size to seven within 90 days (changes thereafter require lender consent); an independent director’s approval is required for any voluntary bankruptcy action by direct domestic subsidiaries.
• Security & priority: An intercreditor agreement gives first‑lien lenders priority over second‑lien lenders in shared collateral; customary standstill and turnover provisions apply. The prior credit agreement was terminated at closing with no early termination penalties.

Why It Matters
This filing shows the company has restructured its debt profile with new secured term loans that extend maturities for five years but carry relatively high financing costs (notably the first‑lien margins and potential PIK fee while leverage is high). For investors, key implications include the impact of higher interest expense on future cash flow, new lender rights that affect board composition and certain corporate actions, and prioritized secured debt that shapes recovery in a downside scenario. Review the full credit agreements (Exhibits 10.1–10.3) for complete terms and covenants.